NIH-funded research R01 grant

Molecular imaging of cholinergic signals and brain pathology in early Alzheimer’s

Official title: Molecular Imaging of Cholinergic Integrity and Neuropathology in Mild Cognitive Impairment

Funded at Johns Hopkins University · NIH-11447190 · Data updated 2026-11-12

This project uses brain imaging to study how the cholinergic system and Alzheimer’s pathology unfold in people at risk for dementia.

More Cognitive Impairment research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionJohns Hopkins University
NIH-funded
Lab location1 site (Baltimore, United States)
Project startSeptember 15, 2026
Project endMay 31, 2031
Funding year2026
Award (this year)$678,939
NIH project number1R01AG098324-01A1
Project IDNIH-11447190 on NIH RePORTER

Who could benefit from this research

Could help

Adults at risk for or showing early signs of Alzheimer’s disease, including mild cognitive impairment and individuals with underlying risk factors.

Less likely to help

Participants without risk factors or early symptoms may not directly benefit beyond contributing to general knowledge.

What this research studies

Researchers will use advanced PET imaging to visualize the cholinergic system and Alzheimer’s-related brain changes in individuals at early disease stages. The study builds on neuropathology and animal model findings to map when cholinergic deficits appear and how they relate to tau, beta-amyloid, cognitive symptoms, and neuropsychiatric changes. By following participants over time, they aim to identify early biomarkers that predict progression and potential targets for prevention or treatment. The work focuses on translating basic discoveries into ways to identify and intervene before significant neurodegeneration occurs.

Why it matters

Potential benefit: If successful, this study could lead to earlier detection and targeted interventions that slow or prevent cognitive decline.

How similar studies have gone: Previous imaging studies have linked cholinergic deficits with dementia severity, supporting a continued exploration in preclinical stages.

Where this research is happening

  • Johns Hopkins University
    Baltimore, United States
    Active

Researchers

  • Principal investigator: Smith, Gwenn S — Johns Hopkins University
  • Study coordinator: Smith, Gwenn S

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.